Editas Medicine, Inc. (EDIT)
Latest EDIT Insider Trades
About Editas Medicine, Inc. (EDIT)
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
- CAMBRIDGE, MA
- 87
- 2016
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 22,181 | $60K |
| Grant or award | 6 | 361,900 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
EDIT Insider Transactions (Form 4)
2626 Form 4 filings on record, the earliest from Dec 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Patrick Thomas Ellinor II - Director | Grant or award | Stock Option (right to buy) | 103,400 |
Recent EDIT Form 8-K Filings
5Recent EDIT Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
EDIT Insider Trading - FAQ
What is the latest insider trade for EDIT?
Editas Medicine, Inc. (EDIT) had 11 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for EDIT runs to 26 Form 4 filings, the earliest from 2024-12-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying EDIT stock?
No insider purchases of EDIT were filed in the last 90 days.
How many insiders are selling EDIT stock?
5 insider sales of EDIT were filed in the last 90 days, totaling $60K.
Where can I see EDIT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks EDIT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow EDIT insider buys?
Create a free InsiderAlpha account and press Watch on this page to add EDIT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Patrick Thomas Ellinor II view on EDGAR
- - Amy Parison view on EDGAR
- - Linda Burkly view on EDGAR
- - Bernadette Connaughton view on EDGAR
- - Jessica Hopfield view on EDGAR
- - Andrew Hirsch view on EDGAR
- - David Scadden view on EDGAR
- - Elliott M. Levy view on EDGAR
- - Amy Parison view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where EDIT's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track EDIT insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
